Uncover key drivers, emerging technologies, and competitive movements shaping the messenger ribonucleic acid (mrna) synthesis raw materials market from 2025–2034 with trusted insights from The Business Research Company
What Are The Market Size Estimates For The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Now And By 2029?
The messenger ribonucleic acid (mRNA) synthesis raw materials market size has shown marginal growth over recent years. This market is expected to increase from $2.99 billion in 2024 to $3.03 billion in 2025, achieving a compound annual growth rate (CAGR) of 1.5%. Historically, this growth has been influenced by advancements in biomedical research, a rising focus on vaccines and therapeutics, the demand for personalized medicine, strategies for outbreak preparedness and response, and the expansion of the biotech industry.
The market for messenger ribonucleic acid (mRNA) synthesis raw materials is projected to experience consistent growth in the coming years. It is anticipated to reach $3.48 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 3.5%. This growth in the forecast period is primarily driven by factors such as supply chain optimization, expanded commercialization and market reach, increased investments in biotech and pharmaceutical sectors, supportive regulatory frameworks and approvals, and the broadening of therapeutic applications. Major trends identified for the forecast period include the emergence of new market entrants, greater emphasis on quality control and standardization, advancements in intellectual property and licensing, efforts towards global access and equity, and a noticeable shift towards more sustainable and scalable manufacturing methods.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12336&type=smp
Which Long-Term Drivers Are Expected To Sustain The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
The increasing prevalence of cancer and chronic conditions is anticipated to fuel the expansion of the mRNA synthesis raw materials market in the future. Cancer is characterized by the unchecked proliferation of abnormal cells, which can invade adjacent tissues and spread to distant parts of the body through the bloodstream and lymphatic systems. Chronic disorders are generally defined as conditions lasting a year or more, requiring ongoing medical attention, interfering with daily life, or a combination of these factors. These raw materials for mRNA synthesis find application in drug discovery, vaccine development, and the production of RNA-based therapeutics, providing enhanced immunogenicity, greater efficiency, and reduced production timelines for addressing cancer and chronic conditions. For example, data from the American Cancer Society Facts and Figures indicates that in 2022, approximately 1.9 million new cancer diagnoses were made in the US, alongside 609,360 fatalities. Projections for 2023 suggest a marginal rise, with over 1.9 million new cases and around 609,820 deaths. Consequently, the increasing occurrence of cancer and chronic diseases serves as a key driver for the demand for mRNA synthesis raw materials.
How Is The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Classified By Different Segments?
The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented –
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials
What Current And Upcoming Trends Are Shaping The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
Product innovations have emerged as a significant and increasingly popular trend within the mRNA synthesis raw materials market. Major companies operating in this market are dedicating efforts to developing novel products to enhance their competitive standing. For instance, in September 2022, Thermo Fisher Scientific, a US-based company providing instrumentation, reagents, consumables, and software services, introduced Dynabeads Solutions. This bead is designed to facilitate the scaling of GMP-grade mRNA synthesis and purification for vaccine development. Dynabeads Streptavidin for In Vitro Transcription are specifically intended for straightforward solid-phase IVT of cell-free mRNA, allowing the reuse of the DNA template up to six times. This capability reduces the effort needed for plasmid creation while simultaneously increasing mRNA yield on scales ranging from g to g. Moreover, it will contribute to designing a streamlined pipeline, enabling mRNA firms to accelerate their progression from development to commercialization.
Who Are The Primary Market Leaders In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
Major companies operating in the messenger ribonucleic acid (mRNA) synthesis raw materials market include Pfizer Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Moderna Inc., Agilent Technologies Inc., Lonza Group Ltd., Eurofins Scientific, Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Integrated DNA Technologies Inc., Sino Biological Inc., CureVac N.V., LGC Biosearch Technologies, Enzo Biochem Inc, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc, Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.
Download The Full Report Here:
Which Regional Markets Are Emerging As Key Centers For The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
North America was the largest region in the mRNA synthesis raw materials market in 2024. The regions covered in the messenger ribonucleic acid (mRNA) synthesis raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=12336&type=smp
Browse Through More Reports Similar to the Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market 2025, By The Business Research Company
Rna Targeting Small Molecules Therapeutics Global Market Report 2025
Antisense And Rnai Therapeutics Global Market Report 2025
Ngs Based Rna Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model